Alterity Therapeutics Ltd.ASX: ATH

Application for quotation of securities - ATH

Jul 27, 2026 at 8:57 PM EDT · Issued by Alterity Therapeutics Ltd. via ASX

Filed with ASX · Jul 27, 2026 at 8:57 PM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-ath-8

Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 8 Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Announcement Type New announcement Date of this announcement Tuesday July 28, 2026 The +securities to be quoted...

View Attachment

6ix hasn’t read this filing yet.

Alterity Therapeutics Ltd. on 6ix

Earlier from Alterity Therapeutics

Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026Jul 21
ATH Receives A$3.98m R&D Tax IncentiveJul 9
Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System AtrophyJul 7
FDA Meeting Minutes Confirm Registrational Path for ATH434Jul 6
Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System AtrophyMay 18

Later from Alterity Therapeutics

Upcoming Expiry of ATHO Listed OptionsJul 28
Quarterly Activities/Appendix 4C Cash Flow ReportJul 29
Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate UpdateJul 30
Alterity to Present at Canaccord Genuity Growth ConferenceAug 5
Granted New U.S. Composition of Matter Patent for ATH434Aug 11

All Alterity Therapeutics news releases

Follow Alterity Therapeutics into a list and get an email when it puts out news.

Follow Alterity Therapeutics